Healthcare -
Biotechnology - NASDAQ - US
$ 1.15
0.877 %
$ 152 M
Market Cap
-0.41
P/E
RAPT - STOCK-BASED COMPENSATION
Stock-based Compensation RAPT - RAPT Therapeutics, Inc.
17.1 M
LAST VALUE
31.05%
2 YEAR CAGR
70.97%
5 YEAR CAGR
0.00%
10 YEAR CAGR